Quantitation and characterization of human plasma neurotensin-like immunoreactivity in response to a meal.
The secretion and metabolism of endogeneous neurotensin-like immunoreactivities after a test meal were studied in five healthy human subjects. Intact neurotensin and the N-terminal metabolic fragment, neurotensin 1-8, were quantified by radioimmunoassay with C- and N-terminally directed antisera in conjunction with gel filtration of plasma samples obtained at timed intervals. Both C- and N-terminal neurotensin-like immunoreactivities rose after the meal, reaching a plateau level after 20 and 30 min, respectively. During the plateau phase, which lasted for the rest of the experimental period of 180 min, the molar ratio of intact neurotensin to neurotensin 1-8 remained approximately constant at 1:4.6. Meal-stimulated immunoreactive neurotensin appeared to be metabolized in a manner comparable to that of exogenously infused neurotensin in man. The results suggest that intact neurotensin is secreted at an approximately constant rate during the plateau phase. The relatively low plateau level of neurotensin 1-8, which has a much longer half-life than intact neurotensin in the circulation, implies that only a fraction of the secreted intact neurotensin is metabolized to neurotensin 1-8, indicating the existence of alternative pathways of neurotensin metabolism.
D000293:Adolescent; D000328:Adult; D002850:Chromatography, Gel; D005260:Female; D006801:Humans; D008297:Male; D009419:Nerve Tissue Proteins; D009479:Neuropeptides; D009496:Neurotensin / Q000031:analogs & derivatives / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives; D011863:Radioimmunoassay
D009419:Nerve Tissue Proteins; D009479:Neuropeptides; D010446:Peptide Fragments; C031644:neurotensin-like immunoreactivity; D009496:Neurotensin; C041968:neurotensin (1-8); D011761:Pyrrolidonecarboxylic Acid